Sign in

You're signed outSign in or to get full access.

Thomas Sedlak

Chief Executive Officer, Precision Marshall at LIVE VENTURESLIVE VENTURES
Executive

About Thomas Sedlak

Thomas Sedlak, 54, is Chief Executive Officer of Precision Industries, Inc. (Precision Marshall), a Live Ventures subsidiary, appointed July 14, 2020; he previously served as Senior Vice President beginning November 2017, Manager of Operations beginning October 2008, and earlier as Controller . He holds a Bachelor’s degree from Robert Morris University and an MBA from the University of Pittsburgh’s Katz Graduate School of Business; earlier career roles included financial management and controllership at PPG Industries and DQE Energy Services . Company performance context during his tenure: Revenues increased from $355.2M in FY 2023 to $472.8M in FY 2024, while EBITDA declined from $29.7M (FY 2023) to $21.6M (FY 2024); FY 2024 net income was a loss of $26.7M and the cumulative TSR declined to $53.73 (value of $100 investment) in FY 2024 (revenues and EBITDA from S&P Global). Revenues FY2023: $355.2M ; Revenues FY2024: $472.8M ; EBITDA FY2023: $29.7M ; EBITDA FY2024: $21.6M.

Values retrieved from S&P Global. Items marked with * have no document citation.

Past Roles

OrganizationRoleYearsStrategic impact
Precision Industries, Inc. (Precision Marshall)Chief Executive OfficerJul 14, 2020–presentLeads subsidiary operations and execution post-acquisition .
Precision Industries, Inc.Senior Vice PresidentNov 2017–Jul 2020Senior leadership over operations ahead of CEO transition .
Precision Industries, Inc.Manager of OperationsOct 2008–Nov 2017Oversaw plant/operations management .
Precision Industries, Inc.ControllerPrior to Oct 2008Financial controls and reporting foundation .
PPG IndustriesFinancial management/controllershipPrior to joining Precision MarshallCorporate finance experience .
DQE Energy ServicesFinancial management/controllershipPrior to joining Precision MarshallCorporate finance experience .

External Roles

OrganizationRoleYearsNotes
No current external directorships or other public company roles disclosed in the proxy .

Fixed Compensation

MetricFY 2023FY 2024
Base salary ($)446,749 504,857
All other compensation ($)90,044 (vehicle allowance $21,800; deferred comp $63,704; life insurance $4,540) 104,926 (vehicle allowance $28,800; deferred comp $71,586; life insurance $4,540)

Perquisites and Deferred Compensation Detail

ComponentFY 2023FY 2024
Vehicle allowance ($)21,800 28,800
Deferred compensation ($)63,704 71,586
Life insurance premiums ($)4,540 4,540

Performance Compensation

ElementStructureTargetWeightingActual payout FY 2023Actual payout FY 2024
Annual bonusAnnual cash incentiveUp to 100% of base salary 75% EBITDA; 25% discretionary 681,832 325,000

The Compensation Committee did not utilize benchmarking or a formal peer group; pay mix emphasizes base salary and annual cash bonus; no equity awards to Sedlak in 2023–2024 .

Equity Ownership & Alignment

ItemStatus
Beneficial ownership (shares)Not listed with any beneficially owned shares as of May 9, 2025 (table shows “—”) .
Percent of outstanding“—” (not shown; implies <1% and no disclosed holdings) .
Options outstanding (FY-end 2024)None (no options listed for Sedlak) .
Stock/RSU awards outstandingNone disclosed; no stock awards in 2023–2024 for Sedlak .
Hedging policyCompany prohibits hedging transactions designed to offset declines in Company securities value .
PledgingNo pledging by Sedlak disclosed (not mentioned) .
Ownership guidelinesNot disclosed for executives (no policy noted in proxy) .

Employment Terms

TermDetail
AgreementPrecision Marshall employment agreement effective July 14, 2020 (as amended), term through Sep 30, 2027 .
Base salaryAt least $475,000 .
Annual bonusUp to 100% of base; 75% tied to mutually agreed EBITDA targets; 25% discretionary .
Benefits/perquisitesVehicle allowance $2,400/month; $400/month toward premiums on a $4.0M life policy; annual contribution equal to 15% of base salary under deferred comp agreement; standard health/benefits .
Severance (termination without Cause)9 months’ continued base salary plus prorated annual bonus for year of termination (based on performance) .
Change-of-controlIf terminated (other than for Cause, death, disability) within six months post-CoC, severance equals 24 months of base salary (double-trigger) .
Restrictive covenantsCustomary confidentiality, non-compete, non-solicit, and non-disparagement .

Company Performance Context (for incentive alignment)

MetricFY 2023FY 2024
Revenues ($)355,171,000 472,840,000
EBITDA ($)29,706,000 21,627,000*

Values retrieved from S&P Global. Items marked with * have no document citation.

MeasureFY 2022FY 2023FY 2024
Value of $100 investment (TSR)67.70 112.93 53.73
Net income ($000s)24,741 (102) (26,685)

Compensation Committee and Governance Notes

  • Compensation Committee members: Richard D. Butler, Jr. (Chair), Dennis (De) Gao, Tyler Sickmeyer; all independent under Nasdaq/SEC rules .
  • No external compensation consultants and no benchmarking/peer group used for NEO pay in FY 2024 .
  • Say-on-pay: Stockholders vote on a triennial basis; Board recommends “once every three years” for frequency; prior vote in 2022 had overwhelming approval of NEO compensation .

Investment Implications

  • Alignment and selling pressure: Sedlak had no disclosed beneficial ownership and no outstanding equity awards at FY-end 2024, indicating low potential insider selling pressure from him—but also weaker long-term equity alignment versus cash-heavy incentives .
  • Incentive design and execution risk: Annual bonus is heavily EBITDA-based (75%), which ties pay to operating performance but may bias toward near-term EBITDA optimization; discretionary 25% adds subjectivity .
  • Retention risk: Contract runs through Sep 30, 2027; severance provides 9 months base on termination without Cause and a double-trigger 24-month base multiple on CoC termination—moderate protection that may aid retention despite limited equity lock-in .
  • Governance context: No pay benchmarking and simple cash-centric design reduce pay inflation risk but may under-reward sustained value creation; company TSR and net income deteriorated in FY 2024, so monitoring future bonus target rigor and subsidiary-level EBITDA goal setting is prudent .